Affordable Access

Access to the full text

Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: a comparative cross-sectional study

Authors
  • Chen, Jing-Xu1
  • Feng, Jun-Hui2
  • Zhang, Li-Gang1
  • Liu, Yan3
  • Yang, Fu-De1
  • Wang, Shao-Li1
  • Tan, Yun-Long1
  • Su, Yun-Ai4
  • 1 Beijing HuiLongGuan Hospital, Peking University HuiLongGuan Clinical Medical School, Beijing, China , Beijing (China)
  • 2 Jining Psychiatric Hospital, Jining, Shandong Province, China , Jining (China)
  • 3 The Department of Psychiatry of Shengli Hospital, Sinopec Shengli Petroleum Administration, Dongying, Shandong Province, China , Dongying (China)
  • 4 Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China , Beijing (China)
Type
Published Article
Journal
BMC Psychiatry
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Sep 29, 2020
Volume
20
Issue
1
Identifiers
DOI: 10.1186/s12888-020-02891-8
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundIndividuals with major depressive disorder (MDD) have a high suicide risk. Some evidence suggests that uric acid (UA) may be involved in the pathophysiology of MDD. The purpose of this study was to evaluate whether serum UA levels were associated with suicide risk in MDD patients.MethodsOne hundred four female patients with MDD (52 patients with suicide risk and 52 patients without suicide risk) and 52 healthy individuals were included in this study. The suicide risk was evaluated by Mini International Neuropsychiatric Interview (M.I.N.I.). Fasting serum levels of UA, as well as glucose, lipid and renal function indicators were measured.ResultsSerum UA levels in MDD patients with suicide risk (245.01 ± 55.44 μmol/L) were significantly lower than those in MDD patients without suicide risk (274.17 ± 72.65 μmol/L) (p = 0.017) and healthy controls (271.42 ± 55.25 μmol/L) (p = 0.030). There was no difference in serum UA levels between the MDD patients without suicide risk and healthy controls (p = 0.821). Binary logistic regression analysis revealed a significant relationship between suicide risk and decreased serum UA levels (OR = 0.989, p = 0.010) in MDD patients.ConclusionDecreased serum UA levels were associated with suicide risk in MDD patients. Purinergic system dysfunction may be involved in the neurobiological basis of suicide risk in these patients.

Report this publication

Statistics

Seen <100 times